for for third XXXX. the thanks, and call everyone, quarter Ezgi, joining our you, update business Thank of
our performance, and to of improvements of and ensure the experience in to available received patients on monitor advance of is our invest must and report, Inspire technology have website. surpassed have outcomes safe our therapy XX,XXX annual effective the is further Inspire programs publication this including patient therapy. which what is we important delivery most with To start call, we in Let's patients. ongoing And as continually therapy, patient who and system-level that our
review Dr. would publication the I Today, the peer Clinical of Journal real-world recent Medicine The by by XX,XXX showing original from reviewed Inspire as FDA XXXX. individual the improvement well Sleep in site in patients as with since continued experience a like to a approval in reviewed University investigators safety announce over Thomas that data patient led reviewing company and as Jefferson Colin documented experience databases. FDA
be from STAR within the and fact, to X.X%, year after in from explant trial. nerve been reported In sleep stimulation what revision reported implant, obstructive which is of first the treatment the new less originally rates These apnea. data X.X% hypoglossal improvements expected significant the both have rates on as set than shown are bar
our performance, we the quarter. strong representing revenue $XXX.X and quarter, This million, successful third of data of business into third proud we XXXX. quarter a compared In third report XX% a increase to translates the are generated to
well as Third result quarter million, also XX therapy existing market in the centers XX% as centers United expansion of greater U.S. This implanting period into growth increased penetration territories. same and as primarily sales adoption reflects the XX year. a last increase over new revenue a revenue in U.S. $XXX.X States new totaled
in reimbursed over to the is last and U.S. the $X.X and of sales saw consistent Utilization X,XXX we procedures account year centers We XXX have year-over-year revenue increased the Switzerland, million. Germany, Netherlands U.S., active increased of Outside Belgium, territories. now began strength XXXX. period in by We U.S. same France. quarter and and the second with XX%
million. XXXX revenue of increasing XX% We to growth our guidance revenue million, are $XXX million to XX% to represents XXXX $XXX which $XXX over
to third a hurricanes quarter. Net the million impacts quarter the in as related some solution guidance result compared and reflects income shortage revenue updated for of the This was fourth IV $XX.X headwinds third of net a the per income XXXX. net in million year of loss of compared the share a of $X.XX in to share representing prior $X.XX period, loss quarter per net $X.X
the September, the settings. key earnings attended year seen the $X.XX strong in had the outcomes conferences American highlighting Highlighting Society Inspire FDA Surgical share team guidance to $X.XX. excellent a to Sleep performance few pathway private we year-to-date, full symposium accomplishments. a years Miami. and to exceptional in of including and we academic per fantastic Given conference, are we and raising Academy by Otolaryngology care have In the International how since XX leads faculty, Inspire practice led both approval
in over Inspire's The commitment with policies demonstrated virtually on professionals significant consistent in system. patients national investigators Medicare The with and over of is from easy-to-use resulting and SleepSync outcomes that treated, highlighted plans. publications and established Inspire coverage an all focused trusted proven XX,XXX team therapy highlighted presentations outcomes our patient XXX private a Inspire in
presented investigators PREDICTOR on During also data the these meetings, the study.
qualify As without requiring the BMI a of without concentric procedure. patients presented for component may which on class. wall lateral with reminder, Inspire endoscopy patients significant study data drug-induced sleep initial the that complete therapy a focus than XX, key those identify are a focused is a collapse The who PREDICTOR lower to of is
We will continue physicians discuss to streamline and the patient therapy. to with journey this receive to payers data Inspire
our outpatient $XX,XXX. slight outpatient code final focus the training consistent programs. advance Medicare another the access XXXX increase to over practice XX advanced training Medicare hosted demand to we meet to strong development to Inspire primary XXX education patient initiative pleased our this market for programs see XXXXX, for physician schedule a improve in ENT the are Inspire rate to therapy. have at both medical before continue clinics the and for surgical which we The year-end. of the XXXX is registered an to and calls $XXX.
With for The providers market both with continue we rates final activities, XXXX front, to sleep And payment is year-to-date, we with capacity fee to center fee the rate physician ambulatory hospital national $XX,XXX CPT On for respect with
to care continue drive presence awareness at primary conferences to we increased increase of cardiology our therapy. Inspire and Further,
care to we with a to operating contributed quarter, the DTC a in connect ways found proper program to we strong the believe leverage increase our be has in digital see for continued direct-to-consumer pathway cost. Our health providers. we efficient remains and significant to In patients which third our targeted engagement more a advertising, in and as digital expenses lower patient provides at
our awareness programs will forward, Inspire patient the continue goal enhancing Going of evaluate we DTC regarding therapy. to with
advance We patients' an ability to to appointment patient the on book journey patients' schedule digital experience. scheduling, improve And patient that over scheduling centers With greatly digital first example to their is the increased XXX Inspire to therapy. is the using continue one have we now attempt to receive initiatives improving appointments.
Switching to product development.
soft view history. our promising, the feedback patient designed this new improving the begun a of expect for efficiency We capacity Early U.S. patient management and Inspire and experiences of SleepSync system is and have to patients therapy providers. and follow-ups accessibility programming of comprehensive with availability for launch full increase we enhancing greater year,
system. in the received know, you As neurostimulation August, for we FDA Inspire approval V
time neurostimulator, V We launch for a remain sufficient launch and XXXX. and the corporates we are Inspire sensing respiratory late soft in into inventory, readiness on focused eliminating full capabilities and XXXX a fewer on pressure in company production, track this building operational with with cost. lead. implant component reduced benefits the reduced surgical to We to complexity with physician and the sensing need the to provide believe will the the one and to patient
to to in the continue We we contractors for XXXX. with the scenarios and launch payers are validate coding Medicare help prepared ensure full
early strategy more once to in on XXXX provide expect coding discussions finalize color our We payers. with the we
have the consistent last the With rules pricing current with set system. to final we V old PPS system Inspire Inspire for week, released IV the be
continue remain In and of we the the adoption therapy. patient Inspire summary, focused growth on to
execute driving the strategy effectively our manage flow and more higher and growth provider will patients. partners our of We patient treat capacity of to quality increasing
practice strategies team's advanced independence capacity. Our increasing embedded and key our our new adoption to our and commercial driving all and tools, objective adding implanters, increase and of strategies center providers, which SleepSync training include of the digital provider adding
the Looking to over strategy future remain like review that, of we ahead, drive excited our With his stakeholder place Rick in long-term financials. have appropriate call I'd the turn to confident for and value. are to about our we that